BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  PAION Announces Initiation Of Second U.S. Phase 3 Clinical Trial Of Remimazolam For Procedural Sedation During Bronchoscopy

  June 8, 2015

   · 

  4 min read
• Drug Development

  Eli Lilly Release: Study: Once-Weekly Trulicity (dulaglutide) Provides Greater Blood Sugar Reduction Compared To Once-Daily Victoza (liraglutide) In Japanese Patients After 52 Weeks

  June 8, 2015

   · 

  11 min read
• Drug Development

  Tobira Therapeutics Inc. Completes Patient Recruitment For CENTAUR Phase 2b Study Of Cenicriviroc In NASH With Liver Fibrosis

  June 8, 2015

   · 

  5 min read
• Seoul National University Hospital Announced Pivotal Study Results Published In Gastroenterology

  June 8, 2015

   · 

  4 min read
• BioMidwest

  Breathe Technologies, Inc. Release: New Clinical Study Shows Chronic Respiratory Disease Patients Using Wearable Ventilation Technology Achieved Significant Increase In Exercise Endurance

  June 8, 2015

   · 

  4 min read
• Drug Development

  Janssen Research & Development, LLC Release: New Data Show Initial Use Of Canagliflozin In Combination With Metformin Extended Release Significantly Improves A1C Levels In Adults With Type 2 Diabetes

  June 8, 2015

   · 

  17 min read
• Drug Development

  Eli Lilly’s Basal Insulin Peglispro Shows Superiority To Insulin Glargine In Reducing Hba1c In People With Type 2 Diabetes

  June 8, 2015

   · 

  11 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center Release: Surgical Anesthesia In Young Children Linked To Effects On IQ, Brain Structure

  June 8, 2015

   · 

  5 min read
• Drug Development

  Merck’s KEYTRUDA (pembrolizumab) Receives Conditional Approval In Canada For The Treatment Of Advanced Melanoma

  June 8, 2015

   · 

  7 min read
• Biotech Beach

  Tandem Diabetes Care Announces t:simulator App Now Available For Android Devices

  June 8, 2015

   · 

  2 min read